Full Alliance Group Inc

PINK:FAGI USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.04 Million
Market Cap Rank
#50227 Global
#15333 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$4000.00
About

Full Alliance Group, Inc., a holding company, engages in finance, health, and digital innovation businesses. It develops platforms across blockchain infrastructure, cross-chain fintech applications, health and wellness products and solutions, and ecommerce. The company was formerly known as Beverly Hills Group, Inc. and changed its name to Full Alliance Group, Inc. in April 2017. Full Alliance Gr… Read more

Full Alliance Group Inc (FAGI) - Net Assets

Latest net assets as of September 2025: $3.31 Million USD

Based on the latest financial reports, Full Alliance Group Inc (FAGI) has net assets worth $3.31 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.05 Million) and total liabilities ($2.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $3.31 Million
% of Total Assets 54.61%
Annual Growth Rate N/A
5-Year Change 380.15%
10-Year Change N/A
Growth Volatility 150.8

Full Alliance Group Inc - Net Assets Trend (2005–2024)

This chart illustrates how Full Alliance Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Full Alliance Group Inc (2005–2024)

The table below shows the annual net assets of Full Alliance Group Inc from 2005 to 2024.

Year Net Assets Change
2024-12-31 $3.55 Million +34.75%
2023-12-31 $2.64 Million +274.44%
2022-12-31 $703.85K -3.18%
2021-12-31 $726.95K -1.72%
2020-12-31 $739.64K +350.66%
2019-12-31 $164.12K +119.91%
2018-12-31 $-824.28K -39.82%
2017-12-31 $-589.54K +53.19%
2016-12-31 $-1.26 Million -11.32%
2015-12-31 $-1.13 Million -72.90%
2014-12-31 $-654.29K -204.57%
2008-12-31 $-214.82K -34.63%
2007-12-31 $-159.56K +18.04%
2006-12-31 $-194.67K +5.41%
2005-12-31 $-205.80K --

Equity Component Analysis

This analysis shows how different components contribute to Full Alliance Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 855651400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $236.56K 7.60%
Other Components $15.73 Million 505.25%
Total Equity $3.11 Million 100.00%

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Full Alliance Group Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,635,496 to 3,112,429, a change of 476,933 (18.1%).
  • Net loss of 1,919,000 reduced equity.
  • Other comprehensive income increased equity by 233,421.
  • Other factors increased equity by 2,162,512.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-1.92 Million -61.66%
Other Comprehensive Income $233.42K +7.5%
Other Changes $2.16 Million +69.48%
Total Change $- 18.10%

Book Value vs Market Value Analysis

This analysis compares Full Alliance Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.29x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 $0.00 $0.01 x
2006-12-31 $0.00 $0.01 x
2007-12-31 $0.00 $0.01 x
2008-12-31 $0.00 $0.01 x
2016-12-31 $-0.01 $0.01 x
2017-12-31 $0.00 $0.01 x
2018-12-31 $0.00 $0.01 x
2019-12-31 $0.00 $0.01 x
2020-12-31 $0.00 $0.01 x
2021-12-31 $0.01 $0.01 x
2022-12-31 $0.01 $0.01 x
2023-12-31 $0.02 $0.01 x
2024-12-31 $0.03 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Full Alliance Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -61.66%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -95.90%
  • • Asset Turnover: 0.36x
  • • Equity Multiplier: 1.77x
  • Recent ROE (-61.66%) is below the historical average (-50.46%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 0.00% 0.00% 0.00x 0.00x $-617.30K
2006 0.00% 0.00% 0.00x 0.00x $-345.66K
2007 0.00% -542.81% 0.60x 0.00x $-341.97K
2008 0.00% -431.68% 0.43x 0.00x $-166.78K
2014 0.00% 0.00% 0.00x 0.00x $-489.67K
2015 0.00% 0.00% 0.00x 0.00x $-487.13K
2016 0.00% 0.00% 0.00x 0.00x $-307.06K
2017 0.00% 0.00% 0.00x 0.00x $-327.05K
2018 0.00% 0.00% 0.00x 0.00x $-252.57K
2019 -594.07% -367.42% 0.17x 9.51x $-991.41K
2020 -55.97% -194.82% 0.12x 2.47x $-487.96K
2021 -2.94% 0.00% 0.00x 2.51x $-94.05K
2022 -4.19% 0.00% 0.00x 2.59x $-99.86K
2023 -38.06% -21.96% 0.90x 1.93x $-1.27 Million
2024 -61.66% -95.90% 0.36x 1.77x $-2.23 Million

Industry Comparison

This section compares Full Alliance Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Full Alliance Group Inc (FAGI) $3.31 Million 0.00% 0.83x $77.66
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million